Close

Novavax (NVAX) discloses a $500 million at-the-market offering via B.Riley

Go back to Novavax (NVAX) discloses a $500 million at-the-market offering via B.Riley

Form 8-K NOVAVAX INC For: Jun 15

June 15, 2021 8:09 AM EDT

Exhibit 1.1

 

NOVAVAX, INC.

 

Common Stock

(par value $0.01 per... More

Form 424B5 NOVAVAX INC

June 15, 2021 8:06 AM EDT

 

 As Filed Pursuant to 424(b)(5)
 Registration No. 333-237094

 

CALCULATION OF REGISTRATION FEE

... More

Form 8-K NOVAVAX INC For: Jun 14

June 14, 2021 5:05 PM EDT

Exhibit 99.1

 

 

Novavax COVID-19 Vaccine Demonstrates 90% Overall
Efficacy and 100% Protection Against Moderate and Severe
Disease in PREVENT-19 Phase 3... More